RLFTY

$0.42-$1.31 (-75.62%)prev close

Compare

Change$-26.16

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

52-week range

$0.27 – $4.90

3% from low

Exchange

OTC Link

ADRC

P/S (TTM)

0.6

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$5M	+28.3%	$0.00	$0.00–$0.00	—	0
2027	$34M	+632.2%	$0.00	$0.00–$0.00	—	0

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

DCF fair valuemodel estimate

Intrinsic value

$0.50

Price

$0.42

Implied upside

+18%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
RLFTYMindMaze Therapeutics Holding S.A.	$0.42	+0.00%	$5M	—
ACHFFArch Biopartners Inc.	$0.65	-0.51%	$44M	—
CLTEFClara Technologies Corp.	$0.18	+0.00%	$11M	—
HBPCFHelix BioPharma Corp.	$1.71	+0.00%	$131M	—
INNMFAmplia Therapeutics Limited	$0.09	+0.00%	$46M	—
OTLCOncotelic Therapeutics, Inc.	$0.03	-0.93%	$13M

Source: Financial Modeling Prep · peers by sector/industry

MINDMAZE THERAPUTCS S/ADR

Held by traders on TradeandTell

No one on the platform currently holds RLFTY.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in RLFTY as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Stock splits

Execution date	Ratio
2023-05-05	1-for-2reverse
2022-11-03	3-for-4reverse

Recent trades on TradeandTell

No one on the platform has traded RLFTY yet.